Latest filing published 31 Mar 2016 for PROVECTUS BIOPHARMACEUTICALS, INC., €118k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter R. Culpepper: trading record in brief
Peter R. Culpepper is a declared insider of Provectus Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 34 filings; the first trade dates from 31 December 2005 and the latest from 29 March 2016.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 29 option exercises.
The latest filing, published on 31 March 2016, reports a transaction of €118k in Provectus Biopharmaceuticals, Inc. The most recent open-market purchase was published on 3 December 2012, 5,088 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Peter R. Culpepper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 133,333 shares@ US$1.00Common StockSEC:0000899243-16-017260:0
- 27,333 shares@ US$1.00Common StockSEC:0000899243-16-017260:1
- 106,000 shares@ US$1.00Common StockSEC:0000899243-16-017260:2
- 138,831 shares@ US$0.94Common StockSEC:0001140361-15-044135:0
- 6,383 shares@ US$0.94Common StockSEC:0001140361-15-044135:1
- 33,334 shares@ US$0.75Common StockSEC:0001140361-15-000969:0
- 29,786 shares@ US$0.94Common StockSEC:0001140361-15-000969:1
- 100,000 shares@ US$1.25Common StockSEC:0001140361-14-027129:0
- 68,624 shares@ US$1.10Common StockSEC:0001140361-14-010099:0
- 121,000 shares@ US$1.10Common StockSEC:0001140361-14-010099:1
- 133,333 sharesCommon StockSEC:0001140361-12-049419:0Canonical exit: 3 Mar 2013 (T+90)
- 133,333 sharesCommon StockSEC:0001140361-12-048272:0Canonical exit: 14 Feb 2013 (T+90)
- 133,333 shares@ US$0.75Common StockSEC:0001140361-11-024848:0
- 133,333 shares@ US$0.75Common StockSEC:0001140361-10-051619:0
- 150,000 shares@ US$0.64Common StockSEC:0001140361-09-014495:0
- 44,795 shares@ US$1.10Common StockSEC:0001140361-08-015046:0
- 50,000 shares@ US$0.64Common StockSEC:0001140361-07-021598:0
- 25,000 shares@ US$0.64Common StockSEC:0001140361-07-018109:0
- 75,000 shares@ US$0.64Common StockSEC:0001140361-07-017206:0
- 3,500 shares@ US$1.10Common StockSEC:0001140361-06-017224:0
- 3,500 shares@ US$1.10Common StockSEC:0001140361-06-015127:0
- 3,500 shares@ US$1.10Common StockSEC:0001140361-06-013841:0
- 3,500 shares@ US$1.10Common StockSEC:0001005794-06-000419:0
- 3,500 shares@ US$1.10Common StockSEC:0001005794-06-000344:0
- 3,500 shares@ US$1.10Common StockSEC:0001005794-06-000321:0
25 of 31 declarations